Docusign, INC Form 4 insider transactions

DocuSign executive Daniel Springer executed multiple transactions involving the company's stock, including sales and option exercises, on December 10, 2024.

DocuSign's CEO, Allan Thygesen, has earned 303,901 performance-based stock units (PSUs) after the company's Compensation Committee certified the achievement of performance criteria related to a 2022 award.

Director Anna Marrs acquired 725 shares of DocuSign common stock through the vesting of restricted stock units on December 4, 2024.

Director Mary Agnes Wilderotter acquired 1,068 shares of DocuSign common stock through the vesting of restricted stock units.

Director Daniel D. Springer acquired 1,068 shares of DocuSign common stock through the vesting of restricted stock units.

Director Anna Marrs acquired 1,068 shares of DocuSign common stock through the vesting of restricted stock units.

Director Teresa Briggs of DocuSign, Inc. reported the acquisition of 1,068 shares of common stock and 1,068 restricted stock units on November 29, 2024.

Director Irving Blake acquired 1,068 shares of DocuSign common stock through the vesting of restricted stock units.

Director James A. Beer of DocuSign, Inc. reported the acquisition of 1,068 shares of common stock and 1,068 restricted stock units, as well as the disposal of 11,783 shares held indirectly through a trust.

Director Cain A. Hayes acquired 1,068 shares of DocuSign common stock through the vesting of restricted stock units.

Director Peter Solvik of Docusign, Inc. reports the acquisition of 1,068 shares of common stock and 1,068 restricted stock units, along with the disposal of 3,917 shares.

DocuSign's CEO, Allan Thygesen, sold a total of 7,763 shares of common stock on December 2, 2024, under a pre-arranged 10b5-1 trading plan.

Docusign director Enrique T. Salem acquired 1,068 shares of common stock through the vesting of restricted stock units.

DocuSign's CEO, Allan Thygesen, sold 7,764 shares of common stock on November 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

DocuSign's CFO, Blake Jeffrey Grayson, sold 9,552 shares of common stock on October 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.

James P. Shaughnessy, Chief Legal Officer of DocuSign, sold shares of common stock on October 9, 2024, under a pre-arranged 10b5-1 trading plan.

DocuSign's CEO, Allan Thygesen, sold shares of common stock on October 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Robert Chatwani, President and General Manager of Growth at DocuSign, sold 14,799 shares of common stock at an average price of $55.46 on September 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.

James P. Shaughnessy, Chief Legal Officer of DocuSign, sold 3,600 shares of common stock in two transactions on September 17 and 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.

DocuSign's Chief Financial Officer, Blake Jeffrey Grayson, sold 14,036 shares of common stock on September 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.

DocuSign's CEO, Allan C. Thygesen, reported the vesting and disposal of shares and restricted stock units (RSUs) to cover tax obligations.

Director Teresa Briggs sold 534 shares of DocuSign (DOCU) common stock at $56.56 per share on September 16, 2024, under a pre-arranged 10b5-1 trading plan.

Robert Chatwani, President and General Manager, Growth at DocuSign, reported the vesting and disposal of shares related to restricted stock units and performance stock units on September 15, 2024.

DocuSign's Chief Financial Officer, Blake Jeffrey Grayson, reported the acquisition and disposal of common stock and restricted stock units on September 15, 2024.

James P. Shaughnessy, Chief Legal Officer of DocuSign, reports the acquisition and disposal of DocuSign stock and derivative securities.

Director Daniel D. Springer reports the vesting and disposal of DocuSign stock and restricted stock units.

Director Anna Marrs reported the vesting and disposal of DocuSign common stock and restricted stock units on September 4, 2024.

DocuSign's CEO, Allan Thygesen, sold 7,725 shares of common stock on September 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Enrique T. Salem of Docusign, Inc. reports the acquisition of 1,068 shares of common stock through the exercise of restricted stock units on August 29, 2024.

Director Teresa Briggs reported the vesting and disposal of 1,068 shares of DocuSign common stock on August 29, 2024.